{"nct_id":"NCT06245291","title":"Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection","status":"WITHDRAWN","status_verified_date":"2024-06","start_date":"2024-05-01","start_date_type":"ACTUAL","primary_completion_date":"2024-08-01","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABUS"]}